Dr. S. Privalenko, Algemene en Acute Genee… SRL

Dr. S. Privalenko, Algemene en Acute Genee… reported total assets of 359,649 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026).

By total assets for 2025, Dr. S. Privalenko, Algemene en Acute Genee… ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0817.283.495
2018 Antwerp
active in General medical practice activities (NACE 86210)
operating since 17 Jul 2009 (≈ 17 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. S. Privalenko, Algemene en Acute Genee… shows with a free account.

See the score
Profile
SRL since 2009
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−35,508 €
Equity292,427 €
Cash0 €
EBITDA−23,053 €
Total assets359,649 €
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity +29 % Total assets +20 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. S. Privalenko, Algemene en Acute Genee…'s annual accounts

20252024202320222021
Net result−35,508 €
Equity292,427 €
Cash0 €
EBITDA−23,053 €
Total assets359,649 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 17 Aug 2026
  • Year ended 31 Dec 2024filed on 11 Mar 2026
  • Year ended 31 Dec 2023filed on 16 May 2024
  • Year ended 31 Dec 2022filed on 20 Feb 2024
  • Year ended 31 Dec 2021filed on 12 Sep 2022

Dr. S. Privalenko, Algemene en Acute Genee…'s financial analysis

Management and control of Dr. S. Privalenko, Algemene en Acute Genee…

1 active director(s) in the register.

Dr. S. Privalenko, Algemene en Acute Genee…'s shareholders and holdings →

Dr. S. Privalenko, Algemene en Acute Genee…'s publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0817.283.495
VAT number
No VAT activity declared to the CBE
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
17 Jul 2009
Registered office
2018 Antwerp
Latest accounts
2025 · filed on 17 Aug 2026
Activity
General medical practice activities (NACE 86210)

Dr. S. Privalenko, Algemene en Acute Genee… (SRL) has been based in Antwerp since 2009, active in: general medical practice activities. For 2025, it reports a net loss of 35,508 € and equity of 292,427 €; its revenue is not published. Its solvency stands at 81.3%, above the median of its sector (72.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dr. S. Privalenko, Algemene en Acute Genee…

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. S. Privalenko, Algemene en Acute Genee…

What is the revenue of Dr. S. Privalenko, Algemene en Acute Genee…?

Dr. S. Privalenko, Algemene en Acute Genee… files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. S. Privalenko, Algemene en Acute Genee…?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. S. Privalenko, Algemene en Acute Genee…. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0817283495. Its company number (CBE) is 0817.283.495.

Where is the registered office of Dr. S. Privalenko, Algemene en Acute Genee…?

According to the CBE register, the registered office of Dr. S. Privalenko, Algemene en Acute Genee… is in 2018 Antwerp.

What is the equity of Dr. S. Privalenko, Algemene en Acute Genee…?

At the close of the 2025 financial year, the equity of Dr. S. Privalenko, Algemene en Acute Genee… amounts to 292,427 €, a solvency of 81.3% of total assets.

Who manages Dr. S. Privalenko, Algemene en Acute Genee…?

The register lists 1 active mandates at Dr. S. Privalenko, Algemene en Acute Genee…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Dr. S. Privalenko, Algemene en Acute Genee… within its sector?

By total assets for 2025, Dr. S. Privalenko, Algemene en Acute Genee… ranks in the top half of the 9,911 companies in its sector (NACE 8621) in Belgium that filed accounts for that financial year.

Idonis

The full file of Dr. S. Privalenko, Algemene en Acute Genee…

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 25 Aug 2026

No credit card, no commitment.

What each plan unlocks →